P W Kalivas

Author PubWeight™ 153.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 2000 5.19
2 The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 2001 5.18
3 A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 1997 3.80
4 Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci 1996 3.66
5 Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci 2000 3.19
6 Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol 2008 2.83
7 Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 1998 2.71
8 Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 1991 2.58
9 Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral sensitization. J Neurochem 1999 1.86
10 A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior. Neuroscience 1999 1.80
11 Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens. Neuroscience 1998 1.70
12 Repeated cocaine administration attenuates group I metabotropic glutamate receptor-mediated glutamate release and behavioral activation: a potential role for Homer. J Neurosci 2001 1.65
13 Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther 1998 1.54
14 Context-specific enhancement of glutamate transmission by cocaine. Neuropsychopharmacology 2000 1.50
15 Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes Brain Behav 2005 1.43
16 Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J Neurosci 1997 1.37
17 Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs. J Neurosci 1994 1.27
18 NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced sensitization in the rat. J Neurosci 2000 1.23
19 Cystine/glutamate exchange serves as the source for extracellular glutamate: modifications by repeated cocaine administration. Amino Acids 2002 1.23
20 Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J Pharmacol Exp Ther 1995 1.22
21 Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci 1992 1.17
22 The regulation of dopamine transmission by metabotropic glutamate receptors. J Pharmacol Exp Ther 1999 1.17
23 Repeated cocaine administration alters the electrophysiological properties of prefrontal cortical neurons. Neuroscience 2002 1.15
24 Effects of cocaine and footshock stress on extracellular dopamine levels in the ventral striatum. Brain Res 1991 1.14
25 Role of acetylcholine transmission in nucleus accumbens and ventral tegmental area in heroin-seeking induced by conditioned cues. Neuroscience 2006 1.10
26 Cocaine sensitization and craving: differing roles for dopamine and glutamate in the nucleus accumbens. J Addict Dis 2001 1.10
27 Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons. J Pharmacol Exp Ther 1987 1.05
28 Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine. Neuroscience 1998 1.05
29 Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther 1983 1.05
30 Regulation of locomotor activity by metabotropic glutamate receptors in the nucleus accumbens and ventral tegmental area. J Pharmacol Exp Ther 2000 1.04
31 Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex. Neuroscience 1993 1.03
32 Neurotensin: topographical distribution in rat brain by immunohistochemistry. J Comp Neurol 1982 1.03
33 The role of mesoaccumbens--pallidal circuitry in novelty-induced behavioral activation. Neuroscience 1995 1.02
34 Computational model of extracellular glutamate in the nucleus accumbens incorporates neuroadaptations by chronic cocaine. Neuroscience 2008 1.01
35 Neuroadaptations in ionotropic and metabotropic glutamate receptor mRNA produced by cocaine treatment. J Neurochem 1999 1.01
36 Glutamatergic and dopaminergic afferents to the prefrontal cortex regulate spatial working memory in rats. Neuroscience 1999 1.01
37 Behavioral and neurochemical sensitization following cocaine self-administration. Psychopharmacology (Berl) 1994 1.00
38 Context-specific cross-sensitization between systemic cocaine and intra-accumbens AMPA infusion in the rat. Psychopharmacology (Berl) 1996 1.00
39 Expression of D1 receptor mRNA in projections from the forebrain to the ventral tegmental area. Synapse 1997 1.00
40 NAC-1, a rat brain mRNA, is increased in the nucleus accumbens three weeks after chronic cocaine self-administration. J Neurosci 1997 0.97
41 Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience 1983 0.96
42 Repeated daily cocaine alters subsequent cocaine-induced increase of extracellular dopamine in the medial prefrontal cortex. J Pharmacol Exp Ther 1997 0.96
43 Autoradiographic localization of mu-opioid and neurotensin receptors within the mesolimbic dopamine system. Brain Res 1989 0.96
44 Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge. J Pharmacol Exp Ther 1996 0.95
45 Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine. J Pharmacol Exp Ther 1993 0.95
46 Topography and functional role of dopaminergic projections from the ventral mesencephalic tegmentum to the ventral pallidum. Neuroscience 1992 0.95
47 Autoradiographic localization of gamma-aminobutyric acidA receptors within the ventral tegmental area. Neurochem Res 1992 0.94
48 Sensitization to stress and psychostimulants. Involvement of dopamine transmission versus the HPA axis. Ann N Y Acad Sci 1995 0.93
49 Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing. Neuroscience 1984 0.92
50 Sensitization to psychostimulants and stress after injection of pertussis toxin into the A10 dopamine region. J Pharmacol Exp Ther 1991 0.92
51 The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission. Psychopharmacology (Berl) 1997 0.92
52 The mediodorsal nucleus of the thalamus in rats--I. forebrain gabaergic innervation. Neuroscience 1996 0.91
53 Contribution of dihydro-beta-erythroidine sensitive nicotinic acetylcholine receptors in the ventral tegmental area to cocaine-induced behavioral sensitization in rats. Behav Brain Res 2005 0.90
54 A topographically organized gamma-aminobutyric acid projection from the ventral pallidum to the nucleus accumbens in the rat. J Comp Neurol 1994 0.90
55 Repeated cocaine administration into the rat ventral tegmental area produces behavioral sensitization to a systemic cocaine challenge. Behav Brain Res 2001 0.90
56 The mediodorsal nucleus of the thalamus in rats--II. Behavioral and neurochemical effects of GABA agonists. Neuroscience 1996 0.89
57 Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens. Brain Res 1987 0.89
58 Amphetamine lowers extracellular GABA concentration in the ventral pallidum. Brain Res 1990 0.89
59 Substance P in the ventral pallidum: projection from the ventral striatum, and electrophysiological and behavioral consequences of pallidal substance P. Neuroscience 1995 0.89
60 Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine. Brain Res 1987 0.88
61 The effect of cholinergic stimulation in the nucleus accumbens on locomotor behavior. Brain Res 1988 0.88
62 Autoradiographic localization of delta opioid receptors within the mesocorticolimbic dopamine system using radioiodinated [2-D-penicillamine, 5-D-penicillamine]enkephalin (125I-DPDPE). Synapse 1990 0.88
63 Involvement of dopamine and excitatory amino acid transmission in novelty-induced motor activity. J Pharmacol Exp Ther 1994 0.88
64 Sensitization to cocaine and dopamine autoreceptor subsensitivity in the nucleus accumbens. Synapse 1995 0.87
65 Cross-sensitization between foot shock stress and enkephalin-induced motor activity. Biol Psychiatry 1986 0.87
66 Enkephalinergic and GABAergic modulation of motor activity in the ventral pallidum. J Pharmacol Exp Ther 1990 0.87
67 Histamine-induced arousal in the conscious and pentobarbital-pretreated rat. J Pharmacol Exp Ther 1982 0.87
68 Dopamine-independent locomotion following blockade of N-methyl-D-aspartate receptors in the ventral tegmental area. J Pharmacol Exp Ther 2001 0.86
69 Involvement of the ventral tegmental area in locomotion elicited from the nucleus accumbens or ventral pallidum. J Pharmacol Exp Ther 1996 0.86
70 Correlation between behavioral sensitization to cocaine and G protein ADP-ribosylation in the ventral tegmental area. Brain Res 1992 0.86
71 Thyrotropin-releasing hormone: neurogenesis of actions in the pentobarbital narcotized rat. J Pharmacol Exp Ther 1980 0.86
72 Behavioral and neurochemical effect of daily injection with neurotensin into the ventral tegmental area. Brain Res 1985 0.86
73 Interactions of neurotensin with brain dopamine systems. Ann N Y Acad Sci 1982 0.85
74 Neuropharmacology of addiction--setting the scene. Br J Pharmacol 2008 0.85
75 Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J Pharmacol Exp Ther 1987 0.84
76 Effect of microinjections of apamin into the A10 dopamine region of rats: a behavioral and neurochemical analysis. J Pharmacol Exp Ther 1990 0.84
77 AGS3: a G-Protein regulator of addiction-associated behaviors. Ann N Y Acad Sci 2003 0.84
78 The role of the nucleus accumbens in sensitization to drugs of abuse. Prog Neuropsychopharmacol Biol Psychiatry 1992 0.84
79 Blockade of enkephalinergic and GABAergic mediated locomotion in the nucleus accumbens by muscimol in the ventral pallidum. Jpn J Pharmacol 1989 0.84
80 High sensitivity HPLC assay for GABA in brain dialysis studies. J Neurosci Methods 1991 0.82
81 The relationship between MRNA levels and the locomotor response to novelty. Brain Res 1994 0.82
82 In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists. Neuropharmacology 1991 0.82
83 Increase in spontaneous motor activity following infusion of neurotensin into the ventral tegmental area. Brain Res 1981 0.82
84 Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus. J Pharmacol Exp Ther 1994 0.82
85 GABAergic projection from the ventral pallidum and globus pallidus to the subthalamic nucleus. Synapse 1995 0.82
86 Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II. Involvement of the mesolimbic dopamine system. J Pharmacol Exp Ther 1985 0.82
87 Neurotensin binding to dopamine. J Neurochem 1990 0.82
88 GABAA receptors containing alpha 1 and beta 2 subunits are mainly localized on neurons in the ventral pallidum. Synapse 1991 0.82
89 Neuroanatomical site specific modulation of spontaneous motor activity by neurotensin. Eur J Pharmacol 1982 0.82
90 Robustness of G protein changes in cocaine sensitization shown with immunoblotting. Synapse 1993 0.82
91 Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo. Neuroscience 1994 0.81
92 Possible role for G-proteins in behavioral sensitization to cocaine. Brain Res 1991 0.81
93 Autoradiographic localization of angiotensin II receptor binding sites on noradrenergic neurons of the locus coeruleus of the rat. J Neurochem 1990 0.81
94 Expression of glutamate receptor subunit/subtype messenger RNAS for NMDAR1, GLuR1, GLuR2 and mGLuR5 by accumbal projection neurons. Brain Res Mol Brain Res 1999 0.81
95 Neurotensin neurons in the ventral tegmental area project to the medial nucleus accumbens. Brain Res 1984 0.81
96 The effects of local application of ethanol in the n. accumbens on dopamine overflow and clearance. Alcohol 1997 0.81
97 Dopaminergic involvement in locomotion elicited from the ventral pallidum/substantia innominata. Brain Res 1991 0.81
98 The involvement of the mediodorsal nucleus of the thalamus and the midbrain extrapyramidal area in locomotion elicited from the ventral pallidum. Behav Brain Res 1999 0.81
99 Effect of adrenalectomy on the initiation and expression of cocaine-induced sensitization. Psychopharmacology (Berl) 1996 0.80
100 Thyrotropin-releasing hormone: central site of action in antagonism of pentobarbital narcosis. Nature 1979 0.80
101 Modulation of extracellular gamma-aminobutyric acid in the ventral pallidum using in vivo microdialysis. J Neurochem 1992 0.80
102 Substance K and substance P differentially modulate mesolimbic and mesocortical systems. Peptides 1985 0.80
103 Substance P modulation of dopamine in the nucleus accumbens. Neurosci Lett 1984 0.80
104 Microinjection of the D2 agonist quinpirole into the A10 dopamine region blocks amphetamine-, but not cocaine-stimulated motor activity. J Pharmacol Exp Ther 1992 0.80
105 Substance K and substance P in the ventral tegmental area. Neurosci Lett 1985 0.80
106 Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole. Psychopharmacology (Berl) 1994 0.80
107 Cross-sensitization between cocaine and acute restraint stress is associated with sensitized dopamine but not glutamate release in the nucleus accumbens. Eur J Neurosci 2013 0.80
108 Changes in gamma-aminobutyric acid, mu-opioid and neurotensin receptors in the accumbens-pallidal projection after discrete quinolinic acid lesions in the nucleus accumbens. Brain Res 1990 0.79
109 Dopamine depletion reorganizes projections from the nucleus accumbens and ventral pallidum that mediate opioid-induced motor activity. J Neurosci 1998 0.79
110 Regional distribution and cellular localization of gamma-aminobutyric acid subtype 1 receptor mRNA in the rat brain. J Comp Neurol 1999 0.79
111 Interaction between thyrotropin-releasing hormone and the mesolimbic dopamine system. Neuropharmacology 1987 0.79
112 The monoamine neurons of the rat brain preferentially express a splice variant of alpha1B subunit of the N-type calcium channel. J Neurochem 1999 0.79
113 Neuroanatomy and neurochemical mechanisms of time-dependent sensitization. Toxicol Ind Health 1995 0.79
114 Endogenous enkephalin modulation of dopamine neurons in ventral tegmental area. Am J Physiol 1986 0.79
115 Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. I. Behavioral characterization. J Pharmacol Exp Ther 1985 0.79
116 Apomorphine decreases extracellular GABA in the ventral pallidum of rats with 6-OHDA lesions in the nucleus accumbens. Brain Res 1992 0.78
117 Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation. Synapse 1992 0.78
118 Novel ideas about novelty. Commentary on Badiani and Robinson drug-induced neurobehavioral plasticity: the role of environmental context. Behav Pharmacol 2004 0.78
119 Bombesin-induced locomotor hyperactivity: evaluation of the involvement of the mesolimbic dopamine system. Brain Res 1984 0.78
120 Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin. Neuropharmacology 1985 0.78
121 Cocaine alters glutamic acid decarboxylase differentially in the nucleus accumbens core and shell. Brain Res Mol Brain Res 1995 0.78
122 Effects of d-amphetamine injected into the nucleus accumbens on ethanol reinforced behavior. Brain Res Bull 1991 0.78
123 Neurotensin: topographical distribution of brain sites involved in hypothermia and antinociception. J Comp Neurol 1982 0.77
124 Neuroanatomical sites of action of neurotensin. Ann N Y Acad Sci 1982 0.77
125 Behavioral cross-sensitization between cocaine and enkephalin in the A10 dopamine region. Behav Brain Res 1988 0.77
126 Chronic haloperidol does not alter G protein alpha-subunit levels in rats. Brain Res Mol Brain Res 1993 0.77
127 Elucidation of Homer 1a function in the nucleus accumbens using adenovirus gene transfer technology. Ann N Y Acad Sci 2003 0.77
128 Antinociception after microinjection of neurotensin into the central amygdaloid nucleus of the rat. Brain Res 1982 0.77
129 Effect of inhibiting enkephalin catabolism in the VTA on motor activity and extracellular dopamine. Brain Res 1992 0.77
130 Postoperative analgesia in dogs receiving epidural morphine plus medetomidine. J Vet Pharmacol Ther 2003 0.77
131 Pertussis toxin in the A10 region increases dopamine synthesis and metabolism. J Neurochem 1992 0.77
132 Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using both mu 1 and delta opioid receptors. Psychopharmacology (Berl) 1995 0.76
133 Microinjection of neurotensin into the ventral tegmental area produces hypothermia: evaluation of dopaminergic mediation. Brain Res 1985 0.76
134 Preliminary evidence for a cocaine-induced embryopathy in mice. Toxicol Appl Pharmacol 1990 0.76
135 Drug addiction: to the cortex.and beyond! Am J Psychiatry 2001 0.76
136 The acute histopathology of MPTP in the mouse CNS. Brain Res Bull 1989 0.76
137 gamma-Aminobutyric acid and mu-opioid receptor localization and adaptation in the basal forebrain. Adv Exp Med Biol 1991 0.76
138 Patterns of glucose use after bicuculline-induced convulsions in relationship to gamma-aminobutyric acid and mu-opioid receptors in the ventral pallidum--functional markers for the ventral pallidum. Brain Res 1992 0.76
139 Behavioral effects of hypothalamic hypophysiotropic hormones, neurotensin, substance P and other neuropeptides. Pharmacol Ther 1984 0.76
140 Thyrotropin releasing hormone (TRH): possible physiological functions not related to the neuroendocrine system. Rev Pure Appl Pharmacol Sci 1984 0.76
141 Dopamine and endogenous opioid regulation of picrotoxin-induced locomotion in the ventral pallidum after dopamine depletion in the nucleus accumbens. Psychopharmacology (Berl) 1992 0.76
142 Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon. Neurosci Biobehav Rev 1985 0.76
143 Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens. J Pharmacol Exp Ther 1986 0.76
144 Nucleus Accumbens 1, a Pox virus and Zinc finger/Bric-a-brac Tramtrack Broad protein binds to TAR DNA-binding protein 43 and has a potential role in Amyotrophic Lateral Sclerosis. Neuroscience 2012 0.76
145 A comparison of 5-hydroxytryptophan effects on rat lumbar spinal cord serotonin release and monosynaptic response amplitude. Brain Res 1989 0.75
146 A catecholaminergic projection from the ventral tegmental area to the diagonal band of Broca: modulation by neurotensin. Brain Res 1985 0.75
147 Response to intracerebral administration of cerebrospinal fluid in the pentobarbital pretreated rat. Neuropharmacology 1980 0.75
148 Possible involvement of serotonergic neurotransmission in neurotensin but not morphine analgesia. Brain Res 1984 0.75
149 Dopamine microinjection into the nucleus accumbens: correlation between metabolism and behavior. Biochem Pharmacol 1985 0.75
150 Neuroanatomical dissociation of thyrotropin-releasing hormone induced shaking behavior and thermogenic mechanisms. Regul Pept 1981 0.75
151 Synchronization of hippocampal and cortical electroencephalogram by thyrotropin-releasing hormone. Exp Neurol 1980 0.75
152 Neurotensin in the ventromedial mesencephalon of the rat: anatomical and functional considerations. J Comp Neurol 1984 0.75
153 Decrease in pentobarbital sleeping time by TRH: characterization with power spectral analysis of EEG. Proc West Pharmacol Soc 1978 0.75
154 Effect of septohippocampal lesions on thyrotropin-releasing hormone antagonism of pentobarbital narcosis. Brain Res 1981 0.75
155 Sensitization to cocaine produced by injection of pertussis toxin into the A10 dopamine region. NIDA Res Monogr 1990 0.75
156 Influence of cholecystokinin on central monoaminergic pathways. Regul Pept 1983 0.75
157 Sexual refractoriness and locomotion effects on brain monoamines in the male rat. Physiol Behav 1987 0.75
158 Failure of muscarinic blockade to antagonize analepsis induced by thyrotropin-releasing hormone and MK-771 in the rat. Psychopharmacology (Berl) 1981 0.75
159 Evidence for interactions of endogenous peptides with the mesolimbic dopamine system. Psychopharmacol Bull 1984 0.75
160 Effects of 5-hydroxytryptophan on extracellular serotonin in the spinal cord of rats with experimental allergic encephalomyelitis. Brain Res 1991 0.75